Bridgewater Associates’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $790K | Sell |
|
|||||
|
2021
Q1 | $950K | Sell |
|
|||||
|
2020
Q4 | $1.48M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $46.6M | Buy |
|
|||||
|
2019
Q2 | $3.96M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $27.1M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $2.12M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $7.8M | Sell |
|
|||||
|
2017
Q3 | $16.5M | Buy |
|
|||||
|
2017
Q2 | $778K | Sell |
|
|||||
|
2017
Q1 | $1.62M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $5.04M | Buy |
|
|||||
|
2014
Q4 | $3.42M | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $4.11M | Sell |
|
|||||
|
2014
Q1 | $7.66M | Buy |
|